Borderline BE study Failure [Study As­sess­ment]

posted by Samaya B – India, 2014-10-14 11:02 (3480 d 10:57 ago) – Posting: # 13696
Views: 7,108

Dear All,

For Product X (IR tablets), full replicated BE study was performed on 56 volunteers under fasting state (EU submission).

When data for first half subjects (N: 28) was analysed, we got following results.
Cmax ratio: 87 (CI: 80.88-95.13)
AUC ratio: 87 (CI: 81.85-94.18)

Analysis of full data set (N: 56)
Cmax ratio: 84.32 (CI: 79.89-89.00)
AUC ratio: 86.9 (CI: 83.02-90.96)

%ISCV Cmax: 25
%ISCV AUC: 20
Power ~100
No outlier detected.

Is there any possibility to get through by any means or study to be repeated?
Or we should go ahead with the reformulation??
PROC GLM is used for stat calculation

Kindly advice.
Thanks!

Regards,
Samaya.


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,656 registered users;
65 visitors (0 registered, 65 guests [including 2 identified bots]).
Forum time: 21:59 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5